RecallRadar

FDA Drug recall D-0017-2027

TIRZEPATIDE 26 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescripti…

On 2026-10-14 the FDA classified a Class II recall of TIRZEPATIDE 26 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescripti… by Carolina Infusion, citing lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0017-2027
ClassificationClass II
Statusongoing
Initiated2026-09-10
Published2026-10-14
Last updated2026-10-21 05:30 UTC
CompanyCarolina Infusion
DistributionUS

Product

TIRZEPATIDE 26 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescription, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936;

Reason

Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.

Identifiers

code_infoLots: 09012026@3, BUD: 10/16/2026; 08032026@16, BUD: 9/17/2026; 08052026@8, BUD: 9/19/2026; 08072026@13, BUD: 9/21/2026.

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-10-21 05:30 UTC. Current status: ongoing.

Other recalls by Carolina Infusion

All Carolina Infusion recalls

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0017-2027%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.